For this reason, inhibition of Acetylcholinesterase enzyme (AChE) and Butyrylcholinesterase enzyme (BuChE), responsible for the hydrolysis of ACh and BCh, has become a treatment option for AD [17]. This evidence concerns the gene ACHE and Alzheimer disease.